Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85

This publication has 9 references indexed in Scilit:

• Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: Report from the DAHANCA 2 study
  International Journal of Radiation Oncology*Biology*Physics, 1989
• Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy
  International Journal of Radiation Oncology*Biology*Physics, 1988
• The influence of haemoglobin concentration on the response to radiotherapy
  Scandinavian Journal of Clinical and Laboratory Investigation, 1988
• The significance of anemia in clinical radiation therapy
  International Journal of Radiation Oncology*Biology*Physics, 1986
• Primary radiotherapy of larynx and pharynx carcinoma—An analysis of some factors influencing local control and survival
  International Journal of Radiation Oncology*Biology*Physics, 1986
• Chemical sensitizers for hypoxic cells: A decade of experience in clinical radiotherapy
  Radiotherapy and Oncology, 1985
• A phase I clinical study of nimorazole as a hypoxic radiosensitizer
  International Journal of Radiation Oncology*Biology*Physics, 1984
• Studies of the pharmacokinetic properties of nimorazole
  British Journal of Cancer, 1983
• A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo
  British Journal of Cancer, 1982